Director at Capricor (NASDAQ: CAPR) sells 115,000 shares via 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
CAPRICOR THERAPEUTICS director Karimah Es Sabar exercised stock options and sold the resulting shares in two days of trading. On March 31, 2026 and April 1, 2026, she exercised options to acquire a total of 115,000 shares of common stock at an exercise price of $4.86 per share and then sold all 115,000 shares in open-market transactions at weighted average prices of $30.1680 and $31.0268, respectively. Following these transactions, no shares from these exercised options remained held, and the sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted in December 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 115,000 shares ($3,515,468)
Net Sell
6 txns
Insider
Sabar Karimah Es
Role
Director
Sold
115,000 shs ($3.52M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 53,735 | $0.00 | -- |
| Exercise | Common Stock | 53,735 | $4.86 | $261K |
| Sale | Common Stock | 53,735 | $31.0268 | $1.67M |
| Exercise | Stock Option (Right to Buy) | 61,265 | $0.00 | -- |
| Exercise | Common Stock | 61,265 | $4.86 | $298K |
| Sale | Common Stock | 61,265 | $30.168 | $1.85M |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock — 53,735 shares (Direct)
Footnotes (1)
- Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.46, inclusive. The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.28 to $31.39, inclusive. Shares vested 25% on August 1, 2022 with the remainder vesting 1/36 per month commencing September 1, 2022.
Key Figures
Shares sold: 115,000 shares
Options exercised: 115,000 shares
Exercise price: $4.86 per share
+3 more
6 metrics
Shares sold
115,000 shares
Total CAPR common shares sold on March 31 and April 1, 2026
Options exercised
115,000 shares
Total underlying shares from stock options exercised at $4.86
Exercise price
<money>$4.86</money> per share
Stock option exercise price for CAPR common stock
Sale price March 31
<money>$30.1680</money> per share
Weighted average sale price for 61,265 shares on March 31, 2026
Sale price April 1
<money>$31.0268</money> per share
Weighted average sale price for 53,735 shares on April 1, 2026
Net share change
-115,000 shares
Net buy/sell shares across reported transactions (net-sell)
Key Terms
Rule 10b5-1, weighted average price, Stock Option (Right to Buy), Exercise or conversion of derivative security, +1 more
5 terms
Rule 10b5-1 regulatory
"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
weighted average price financial
"The price reported on Column 4 is the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
Exercise or conversion of derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
vesting financial
"Shares vested 25% on August 1, 2022 with the remainder vesting 1/36 per month"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What insider transactions did CAPR director Karimah Es Sabar report?
Karimah Es Sabar reported exercising stock options for 115,000 CAPR shares at $4.86 per share, then selling all 115,000 shares in open-market trades around $30–31 on March 31 and April 1, 2026, according to the Form 4.
Were the CAPR insider sales made under a Rule 10b5-1 trading plan?
Yes. The Form 4 footnotes state the CAPR share sales were executed under a Rule 10b5-1 trading plan adopted in December 2025, indicating the transactions were pre-scheduled rather than decided at the time of sale.
What happened to the director’s stock options in this CAPR Form 4?
The director exercised stock options covering 61,265 shares and 53,735 shares of CAPR common stock at $4.86 per share. After these exercises, the reported option positions for these specific grants showed zero remaining shares following the transactions.